recombinant Lactobacillus casei expressing cholera toxin subunit A1-conjugated consensus matrix protein 2 vaccine (International Vaccine Institute/Korea Research Institute of Bioscience and Biotechnology)

N/A

Report date: 2025/03/20 09:34:07

Base Information

Drug Namerecombinant Lactobacillus casei expressing cholera toxin subunit A1-conjugated consensus matrix protein 2 vaccine (International Vaccine Institute/Korea Research Institute of Bioscience and Biotechnology)
Drug Alias Namematrix protein 2 vaccine (International Vaccine Institute/Korea Research Institute of Bioscience and Biotechnology)M2 vaccine (International Vaccine Institute/Korea Research Institute of Bioscience and Biotechnology)
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionMatrix protein 2 modulators
TargetsMatrix protein 2
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInternational Vaccine Institute
China Registration ClassN/A

Develop Information

Active CompaniesKorean Research Institute of Bioscience and BiotechnologyInternational Vaccine Institute
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A